Why does menopause hormone therapy work differently for each person?

Starting vaginal bacteria were linked to different hormone therapy results, including changes in estrogen and sexual function. The report studied women in perimenopause, the years leading up to menopause. It compared responses to menopause hormone therapy across four starting vaginal bacteria patterns. For our [Hormone Optimization Therapy]( /health-practices/hormone-optimization/hormone-optimization-therapy) community, the key takeaway is that starting conditions may matter. Women in one bacteria group had the greatest improvements in blood estrogen and sexual function. Their vaginal bacteria also changed widely. Another group saw moderate benefits. In that group, one type of bacteria, called L. iners, gave way to another, called L. crispatus. Women who started with a wider mix of vaginal bacteria showed limited responses. Those whose samples already had mostly L. crispatus stayed largely stable. Little change in that group reflected a stable bacteria pattern, not necessarily failed treatment. The starting amount of L. crispatus also helped predict a later shift toward that pattern. But the supplied excerpt gives no exact changes in estrogen or sexual function scores. It also leaves cause and effect unclear. These findings do not show that changing vaginal bacteria would improve treatment results. For members tracking their own results, this adds context to community comparisons. Bloodwork and notes about sexual function can tell different parts of the story. Comparing starting results with later changes may be more useful than comparing final numbers alone. Another member’s response may not match yours, even when the treatment sounds similar. What changes have you noticed in your bloodwork and sexual well-being while tracking menopause hormone therapy?